Pinealon

Pinealon — Pineal Gland / CNS Bioregulator

Pinealon is a Khavinson-class short-chain bioregulator peptide that restores youthful gene expression in pineal gland / cns tissue.

Peptide Specifications

Parameter	Value
Sequence	Glu-Asp-Arg
Mass	390.4 g/mol
Purity	>98.0%
Target Organ	Pineal Gland / CNS

Figure 1: Pinealon Organ-Specific Bioregulation

Tissue-Specific Mechanism

1. Tripeptide with profound tropism for the pineal gland.
2. Normalizes circadian-driven melatonin synthesis and release.
3. Corrects age-related pineal calcification effects.
4. Upregulates deep Slow-Wave Sleep architecture.
5. Provides neuroprotective antioxidant activity.

Figure 2: Pineal Gland / CNS Regeneration Curve

Research Results

• 1: Premier bioregulator for sleep quality restoration.
• 2: Normalizes circadian rhythm without exogenous melatonin drowsiness.
• 3: Significant anti-neurodegenerative properties.

Central Nervous System Bioregulator

Pinealon (Glu-Asp-Arg) is a synthetic tripeptide bioregulator targeting central nervous system tissue, specifically designed to normalize brain cell function during aging and neurodegeneration. As a Khavinson-class bioregulator, Pinealon operates through epigenetic modulation—binding DNA in neuronal gene promoter regions to restore youthful transcription patterns. Its name derives from its relationship to pineal gland research, though its activity extends broadly across cortical, hippocampal, and cerebellar neurons. Pinealon is one of the most extensively studied synthetic bioregulators in the Khavinson classification.

1. The Glu-Asp-Arg tripeptide sequence penetrates neuronal nuclei and interacts with specific DNA sequences in the promoter regions of neuroprotective genes.
2. Antioxidant defense gene expression (SOD2, catalase, glutathione peroxidase) is upregulated, strengthening mitochondrial protection against oxidative stress.
3. Anti-apoptotic gene expression (Bcl-2, Bcl-xL) increases while pro-apoptotic signaling (BAX, caspase-3) is attenuated, shifting the balance toward neuronal survival.
4. Melatonin synthesis-related enzymes in pinealocytes are normalized, improving circadian rhythm regulation disrupted by aging.
5. Neurotrophic factor expression (BDNF, NGF) is modestly upregulated, supporting synaptic maintenance and plasticity.

Neuroprotective Research

• Aging Brain: In aged rodent models, Pinealon course administration improved spatial memory (Morris water maze) and increased hippocampal neuron survival density.
• Oxidative Stress: Pinealon pretreatment protects cortical neuron cultures from hydrogen peroxide-induced apoptosis, reducing cell death by 30–40%.
• Circadian Restoration: Normalization of melatonin synthesis helps restore the sleep-wake cycle disruption common in aging and neurodegenerative disease.
• Oral Bioavailability: As a tripeptide, Pinealon is absorbed via PepT1 intestinal transport, allowing oral capsule administration with meaningful CNS bioavailability.
• Course Protocol: 1–2 capsules daily for 30 days, repeated every 3–6 months. Compatible with other bioregulators targeting different organ systems.